MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • MDS Virtual Congress 2020

    Diagnostic utility of cerebrospinal fluid t-tau/p-tau181 in Parkinson’s disease with mild cognitive impairment: A cross-sectional study in Chinese cohort

    P. Zhang, Y. Li, L.J Wang, Y.H Zhang (Guangzhou, China)

    Objective: This study explores the value of α-Syn, Aβ1-42, t-tau, p-tau181 in cerebrospinal fluid(CSF) and their ratios for the diagnosis of Parkinson's disease with mild…
  • MDS Virtual Congress 2020

    Parkinson’s Disease Exhibits Longitudinal Increases in beta-Amyloid in the Striatum and Cingulate Gyrus

    J. O'Donnell, Y. Zhou, M. Campbell, B. Maiti, J. Perlmutter (Saint Louis, MO, USA)

    Objective: To identify longitudinal patterns of beta-amyloid(Ab) accumulation in Parkinson's disease (PD) through the use of Pittsburgh Compound B (PiB) Positron Emission Tomography imaging in…
  • MDS Virtual Congress 2020

    Association between BDNF Val66Met polymorphism and mild behavioral impairment in patients with Parkinson’s patients

    M. Ramezani, J. Ruskey, K. Martens, E. Leveille, Z. Javer, I. Kathol, M. Kibreab, T. Hammer, J. Cheetham, J. Sarna, D. Martino, G. Pfeffer, Z. Gan-Or, Z. Ismail, O. Monchi (Calgary, AB, Canada)

    Objective: This study investigates if PD patients with Brain-derived-neurotrophic-factor (BNDF) Met allele are more likely to have Mild behavioral impairment (MBI). And whether Met allele…
  • MDS Virtual Congress 2020

    Goalkeeper Game: a new assessment tool for prediction of gait performance under complex condition in people with Parkinson’s disease

    R. Stern, M. d'Alencar, Y. Uscapi, M. Gubitoso, A. Roque, A. Helene, M. Piemonte (São Carlos, Brazil)

    Objective: To investigate the use of the GG to predict impairment in gait performance under complex conditions in PPD and compare its predictive power with…
  • MDS Virtual Congress 2020

    The incidence, predictors, and outcomes of delirium in Parkinson’s disease and atypical parkinsonism

    S. Green, A. McCleary, I. Sleeman, J. Maple-Grødem, C. Counsell, A. Macleod (Aberdeen, United Kingdom)

    Objective: To explore (i) the incidence of, (ii) the risk factors for, and (iii) the outcomes after, the first hospital episode of delirium in both…
  • MDS Virtual Congress 2020

    Confrontation Naming Deficit in Lewy Body Dementia Patients with Alzheimer’s Disease Co-Pathology

    E. Howard, D. Irwin, K. Rascovsky, N. Nevler, S. Shellikeri, D. Mechanic-Hamilton, T. Tropea, A. Chen-Plotkin, A. Siderowf, D. Weintraub, L. Shaw, J. Trojanowski, M. Grossman, K. Cousins (Philadelphia, PA, USA)

    Objective: To test the association between confrontation naming performance and Alzheimer’s disease (AD) co-pathology as defined by cerebrospinal fluid (CSF) biomarkers in Lewy body dementia…
  • MDS Virtual Congress 2020

    Deep brain stimulation and cognitive decline in Parkinson’s disease: The predictive value of Alternate Fluency test

    R. Ferrucci, F. Mameli, F. Ruggiero, M. Reitano, S. Marceglia, M. Massei, L. Borellini, F. Cogiamanian, T. Bocci, M. Locatelli, S. Barbieri, A. Averna, A. Priori (Milan, Italy)

    Objective: To study the impact of subthalamic nucleus deep brain stimulation (STN-DBS) on executive function using Alternate Fluency Test (AFT) and to investigate predictors for…
  • MDS Virtual Congress 2020

    Both Symptomatic and Asymptomatic Orthostatic Hypotension is Associated with Cognitive Decline Over Time in Parkinson’s Disease

    K. Longardner, E. Bayram, I. Litvan (San Diego, CA, USA)

    Objective: To compare cognitive changes over time between Parkinson's disease (PD) patients with orthostatic hypotension (OH) and without OH, and between those with symptomatic OH…
  • MDS Virtual Congress 2020

    Meynert Nucleus-related Cortical Thinning in Parkinson’s Disease with Mild Cognitive Impairment

    S.M Rong, Y. Li, B. Li, K. Nie, P. Zhang, TT. Cai, M.J Mei, L.J Wang, Y.H Zhang (Guangzhou, China)

    Objective: To investigate the associations between NBM/Ch4 volume and cortical thickness in PD. Background: Cognitive impairment in Parkinson’s disease (PD) involves the cholinergic system, especially the…
  • MDS Virtual Congress 2020

    Multimodal EEG-MRI based machine learning model in identifying Parkinson’s disease with mild cognitive impairment

    J.H Zhang, L.J Wang, K. Nie (Guangzhou, China)

    Objective: To evaluate the diagnostic value of quantitative electroencephalogram (qEEG) and structure Magnetic resonance (sMR) in identifying mild cognitive impairment in Parkinson’s disease (PD-MCI) via…
  • « Previous Page
  • 1
  • …
  • 44
  • 45
  • 46
  • 47
  • 48
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • VIT-D and Tics Movement Disorder
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley